0002072045-25-000001.txt : 20250611
0002072045-25-000001.hdr.sgml : 20250611
20250611152605
ACCESSION NUMBER: 0002072045-25-000001
CONFORMED SUBMISSION TYPE: SCHEDULE 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20250611
DATE AS OF CHANGE: 20250611
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Quantum Biopharma Ltd.
CENTRAL INDEX KEY: 0001771885
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
EIN: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-91661
FILM NUMBER: 251039779
BUSINESS ADDRESS:
STREET 1: FIRST CANADIAN PLACE
STREET 2: 100 KING STREET WEST, SUITE 4000
CITY: TORONTO
STATE: A6
ZIP: M5X 1A4
BUSINESS PHONE: (416) 854-8884
MAIL ADDRESS:
STREET 1: FIRST CANADIAN PLACE
STREET 2: 100 KING STREET WEST, SUITE 4000
CITY: TORONTO
STATE: A6
ZIP: M5X 1A4
FORMER COMPANY:
FORMER CONFORMED NAME: FSD Pharma Inc.
DATE OF NAME CHANGE: 20190327
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Malone Wealth Ventures LLC
CENTRAL INDEX KEY: 0002072045
ORGANIZATION NAME:
EIN: 861544286
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
BUSINESS ADDRESS:
STREET 1: 9201 W STATE ST. STE 126
CITY: BOISE
STATE: ID
ZIP: 83714
BUSINESS PHONE: 2089854526
MAIL ADDRESS:
STREET 1: 9201 W STATE ST. STE 126
CITY: BOISE
STATE: ID
ZIP: 83714
SCHEDULE 13G
1
primary_doc.xml
SCHEDULE 13G
0002072045
XXXXXXXX
LIVE
Common Stock
06/11/2025
0001771885
Quantum Biopharma Ltd.
74764Y205
FIRST CANADIAN PLACE
100 KING STREET WEST, SUITE 4000
TORONTO
A6
M5X 1A4
Rule 13d-1(b)
Malone Wealth Ventures LLC
ID
16000.00
0.00
447848.00
0.00
447848.00
13.2
IA
Les Gro
Quantum Biopharma Ltd.
FIRST CANADIAN PLACE, 100 KING STREET WEST, SUITE 4000, TORONTO, ONTARIO, CANADA, M5X 1A4
Malone Wealth Ventures LLC
9201 W State St. Ste 126
Boise, ID 83714
United States
N
IA
447,848
13.2
16,000
0
447,848
0
Y
N
N
Clients of Malone Wealth Ventures LLC have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, the securities reported herein. No individual client is known to have such interest relating to more than five percent of the class.
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Malone Wealth Ventures LLC
Kevin M Malone
Chief Executive Officer
06/11/2025